Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
| Autor: | Stacchiotti, S., Saponara, M., Frapolli, R., Tortoreto, M., Cominetti, D., Provenzano, S., Negri, T., Dagrada, G.P., Gronchi, A., Colombo, C., Vincenzi, B., Badalamenti, G., Zuco, V., Renne, S.L., Collini, P., Morosi, C., Dei Tos, A.P., Bello, E., Pilotti, S., Casali, P.G., D'Incalci, M., Zaffaroni, N. |
|---|---|
| Zdroj: | In European Journal of Cancer May 2017 76:84-92 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect